A randomised, double-blinded parallel group study to compare efficacy and tolerability of topically applied Baceca and Tazarotene against placebo and Tazarotene in patients with basal cell carcinoma

Update Il y a 4 ans
Reference: EUCTR2005-001474-27

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objective will be to determine the efficacy of repeated topical applications of Tazarotene together with Baceca or placebo in patients with basal cell carcinomas (BCC).


Inclusion criteria

  • skin cancer of the type of Basal Cell Carcinoma (BCC)

Links